Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials have?
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials has 95 citations in the OpenAlex counts ScholarIQ stores.
When was Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials published?
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials has 2021 year in the ScholarIQ index.
What is the open-access status of Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials?
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials has hybrid oa status in the ScholarIQ index.
What is the DOI of Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials?
The DOI for Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials is on the source record.
What is the PMID of Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials?
The PMID for Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials is on the source record.
What is the OpenAlex record for Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials?
The OpenAlex for Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials is on the source record.